FDA & Regulatory

Recalls, PMA approvals, and adverse events for heart valve devices

50 events
Adverse EventAug 11, 2026
Adverse Event: AORTIC VALVE GRAFT
Adverse EventAug 11, 2026
Adverse Event: MOSAIC
PMA ApprovalJul 27, 2026
FDA PMA: On-X Prosthetic Heart Valves and Ascending Aortic Prothesis

Company: On-X Life Technologies, Inc.

— Applicant: On-X Life Technologies, Inc.

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC RECEIVED INFORMATION THAT 11 YEARS AND 2 MONTHS POST IMPLANT OF THIS 21MM MOSAIC AORTIC BIOPROSTHETIC VALVE, THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. TH...

Adverse EventJul 14, 2026
Adverse Event: HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE

IT WAS REPORTED THAT 12 YEARS AND 6 MONTHS POST IMPLANT OF THIS 27MM AORTIC BIOPROSTHETIC VALVE, THE PATIENT IS BEING EVALUATED FOR A TRANSCATHETER VALVE-IN-VALVE REPLACEMENT. THE REASON FOR EVALUATIO...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

PMA ApprovalJun 22, 2026
FDA PMA: Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valves

Company: ABBOTT MEDICAL

— Applicant: ABBOTT MEDICAL

PMA ApprovalJun 11, 2026
FDA PMA: Masters Series™ Aortic Valved Graft with Hemashield™ Graft Technology (CAVGJ)

Company: ABBOTT MEDICAL

— Applicant: ABBOTT MEDICAL

Adverse EventJun 10, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 23MM AORTIC BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. ...

Adverse EventJun 10, 2026
Adverse Event: OPEN PIVOT AP360 HEART VALVE

MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 28MM OPEN PIVOT MECHANICAL VALVE, IT WAS EXPLANTED AND REPLACED WITH A PRODUCT FROM ANOTHER MANUFACTURER. THE REASON FOR THE REPLACEMENT ...

Adverse EventJun 10, 2026
Adverse Event: HANCOCK II
Adverse EventJun 10, 2026
Adverse Event: AVALUS ULTRA BIOPROSTHESIS

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJun 10, 2026
Adverse Event: AVALUS ULTRA BIOPROSTHESIS

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM PFO Occluder; AmplatzerTM Talisman™ PFO Occluder

Company: ABBOTT MEDICAL

— Applicant: ABBOTT MEDICAL

PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM Muscular VSD Occluder

Company: ABBOTT MEDICAL

— Applicant: ABBOTT MEDICAL

PMA ApprovalMay 28, 2026
FDA PMA: AmplatzerTM Septal Occluder; AmplatzerTM Multifenestrated Septal Occluder - Cribriform

Company: ABBOTT MEDICAL

— Applicant: ABBOTT MEDICAL

Adverse EventMay 25, 2026
Adverse Event: FREESTYLE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventMay 25, 2026
Adverse Event: FREESTYLE AORTIC ROOT BIOPROSTHESIS

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventMay 25, 2026
Adverse Event: MOSAIC MITRAL BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventMay 25, 2026
Adverse Event: AORTIC AP

IT WAS REPORTED THAT DURING AN AORTIC VALVE REPLACEMENT PROCEDURE, A 505DA20 MECHANICAL HEART VALVE WAS IMPLANTED AND ABNORMAL LEAFLET OPENING AND CLOSING OF THE MECHANICAL VALVE LEAFLET WAS OBSERVED ...

Adverse EventMay 25, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 21MM MOSAIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A COMPETITORS VALVE. THE REASON FOR THE REPLACEMENT WAS REPORTED THAT, DURING AN UL...

Adverse EventMay 25, 2026
Adverse Event: HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE

MEDTRONIC RECEIVED INFORMATION THAT PRIOR TO USE OF THIS 27MM HANCOCK II BIOPROSTHETIC VALVE, IT WAS REPORTED THAT THE VALVE WAS FOUND TO HAVE A SUTURE BREAKAGE. UPON OPENING THE VALVE COVER, THE RETA...

RecallMay 25, 2026
Recall: Procedure packs: (1) Presource PBDS, Cat. PC71EXOU7, Ohio State Univ Wexner Med Ctr, Kit, Extractio

Company: Cardinal Health 200, LLC

Packs contain recalled components (equipment drapes, table cover, and surgical room turnover (SRT) kits).

RecallMay 25, 2026
Recall: CryoValve, Pulmonary Heart Valve

Company: Cryolife Inc

Additional information obtained from the Outside Tissue Procurement Organization indicated that the donor's attending physician stated that the patient had pneumonia and it possibly might have been a...

Adverse EventMay 25, 2026
Adverse Event: MOSAIC
RecallMay 25, 2026
Recall: Pulmonary heart valve allograft, human tissue for transplantation.

Company: LifeNet

Recalling firm distributed a heart valve from donor whose sera was found potentially positive for Hepatitis C.